Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Eli Lilly and Company
Novartis
Pharmassist Ltd
AstraZeneca
Actuate Therapeutics Inc.
Novartis
Novartis
Haihe Biopharma Co., Ltd.
Novartis
Celcuity Inc
Novartis
Novartis
Novartis